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This study examined the suitability of a nuclear imaging
technique using 
99mTc-tetrofosmin as an agent to assess the
heart functions of healthy micropigs. The mean age of the
pigs was 360 days (male), and the mean body weight was
35.3 kg ranging from 34.5-36 kg. There were no significant
perfusion defects in any of the reconstructed images.
Gated single-photon emission computed tomography
imaging can be used to calculate the ventricular volume
and ejection fraction (EF). In this case, an EF of 79% was
calculated from the ventricular volume of the end-systolic
image (10 ml) subtracted from that of the end-diastolic
volume (49 ml). A perfusion defect (particularly the apex,
lateral wall) is unlikely because of the presence of a
preserved wall motion in a segment with a defect. It is
concluded that quantitative cardiac scintigraphy, using
99mTc-tetrofosmin is an adequate technique for estimating
the heart functions of healthy micropigs.
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Introduction
Transplantation is the preferred treatment for chronic
failure of the heart, kidneys, lungs, and liver. However,
transplantation has a fairly limited impact on medical
practice due to the lack of organs. It has been estimated that
<10% of the organs needed each year in the United States
become available, and that the percentage is continuing to
decline [3]. Hence, there is increasing interest in the
possibility of using animals as a source of organs and tissues
for xenotransplantation in place of humans. The use of
animals as a source of organs also might allow the transplant
procedure to be planned, providing obvious medical and
surgical benefit. The use of animals also might allow the
transplant to become a means for expressing extrinsic genes,
i.e., as a vehicle for gene transfer.
The species that might best serve as a source of organs or
tissues for xenotransplantation is an important issue. The
most suitable source of organs and its tissues might intuitively
be species such as baboons or other higher primates
genetically similar to humans. Indeed, some of the earliest
trials in allotransplantation involved the use of organs from
higher primates [13,14]. It is possible given modern
approaches to immunosuppression and the availability of
antimicrobial therapy that organs from nonhuman primates
might be made to survive and function for a significant
period in human subjects. Most researchers are looking to
the use of non-primates such as pigs as source of xenograft
tissues and organs for clinical purposes. The reason for this
interest is that these animals are available in sufficient
numbers and can meet the potential needs of all recipients:
1) pigs can be obtained in sizes suitable for mature adults; 2)
pigs present a much lower risk introducing lethal viral
infections into the recipient than nonhuman primates; 3)
pigs can be genetically engineered. There is only limited
information on how well a porcine heart might address this
question.
It is clinically impractical to measure the myocardial
viability in most animals used for heart transplantation, in
which a frequent assessment of the heart functions is
essential for both diagnosis and prognosis. An assessment of
the myocardial viability in pigs with coronary artery disease
and left ventricle dysfunction is of major importance for the
prognosis. Pigs with this condition are at high risk of cardiac
death and usually have significant impairment in their
exercise capacity and daily activity. It is well known that a
left ventricle dysfunction is not necessarily an irreversible
process. A dysfunctional but viable myocardium has the
potential to recover after the restoration of myocardial blood
flow by either coronary arterial bypass grafting or percutaneous
transluminal coronary angioplasty. Therefore, the aim of this
study was to determine the ejection fraction (EF) of healthy
micropigs using nuclear imaging with 
99mTc- tetrofosmin.
*Corresponding author
Tel: +82-62-530-2831; Fax: +82-62-530-2809
E-mail: hjhan@chonnam.ac.kr224 Min Young Lee et al.
Materials and Methods
Animals
Mixed-breed, conditioned micropigs were purchased from
PWG Genetics (Korea). Prior to purchase, physical examinations
were performed and their results were considered to be
normal. The pigs were housed indoors individually in cages,
fed dry pig food, and provided water ad libitum. The age of
the experimental animals was 360 days, respectively. Blood
pressure was measured five times for each individual animal
with Cardell BP monitor (Sharn Veterinary, USA) in the
premedicated condition with atropine (0.04 mg/kg IM),
xylazine (2.2 mg/kg IM), and a zolazepam/tiletamine cocktail
(4.4 mg/kg IM) prior to echocardiographic examination
(Table 1).
Myocardial perfusion gated SPECT
The micropigs were fasted overnight, premedicated with
atropine (0.04 mg/kg IM), xylazine (2.2 mg/kg IM), and
anesthetized with a zolazepam/tiletamine cocktail (4.4 mg/
kg IM). 
99mTc-tetrofosmin 111 MBq was injected intravenously
at rest. Forty minutes after the injection, the planar and
single-photon emission computed tomography (SPECT)
images were acquired in the supine position (Fig. 1). The
acquisition time was 20 seconds with detection every 3
o. The
remaining SPECT study was acquired with an ECG-gated
technique using eight frames for a cardiac cycle. The
SPECT data was acquired using a Discovery VH/Millenium
VG (GE Medical System, USA) with a high-resolution
collimator, setting the energy photo-peak at 140 keV with a
20% symmetric window and a 90
o acquisition arc. The
Emory Cardiac Tool Box program automatically reoriented
the transaxial slices along the vertical long axis, the
horizontal long axis and the short axis [17]. The end-
diastolic (ED) and end-systolic (ES) images were selected
according to the left ventricular cavity size on the gated
SPECT. A polar map was also obtained for all sets. When
displayed, the images were normalized to the maximal
activity registered during the diastole, systole, or during the
overall cardiac cycle. The perfusion defects were assigned to
the vascular territories as follows: defects located in the
apex, anterior, anterolateral, anteroseptal, septal, and
inferoseptal segments were assigned to the left anterior
descending artery territory, the inferior segment was assigned
to the right coronary artery, and the rest (i.e., lateral and
inferolateral segments) were assigned to the left circumflex
artery territories. The defect severity was evaluated using a
semiquantitative five-point scoring system (0, normal
perfusion; 1, mild reduction in counts but not definitely
Table 1. Clinical and laboratory characteristics of the study population
Pig 1 Pig 2 Pig 3
Age (days) 360 360 360
Body weight (kg) 34.5 36 35.5
Body temperature (
oC) 37.3 37.8 38.2
Respiratory rate (/min) (n = 5) 70.00 ± 1.73 71.00 ± 1.53 70.00 ± 2.07
Blood pressure
(mmHg)
SAP (n = 5) 121.56 ± 2.560 123.67 ± 1.760 134.80 ± 2.290
DAP (n = 5) 72.75 ± 5.57 86.67 ± 2.40 71.00 ± 0.95
MAP (n = 5) 81.50 ± 4.17 87.33 ± 2.33 101.80 ± 1.110
SAP: systolic arterial pressure, DAP: diastolic arterial pressure, MAP: mean arterial pressure, n = number of measurements.
Fig. 1. A micropig positioned ventro-dorsally, and restraine d
physically and pharmacologically for an assessment of the
cardiac function using gated 
99mTc-tetrofosmin single photon
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abnormal; 2, moderate reduction in counts and definitely
abnormal; 3, severe reduction in counts; 4, absent uptake).
Statistical analysis
All of the measured values are expressed as a mean ± SD.
Each mean values were analyzed by the Wilcoxon test. A
p < 0.05 was considered significant.
Results
The short-axis (Fig. 2A), vertical long-axis (Fig. 2B) and
horizontal long-axis (Fig. 2C) images were displayed. There
were no significant perfusion defects in any of the
reconstructed images. Gated SPECT imaging allows the
ventricular volumes and EF to be calculated (Fig. 3). In this
Fig. 2. Cardiac perfusion images. A-C: These images showed myocardial perfusion (Yellow arrow: anterior wall, Yellow dotted arrow:
septal wall, white arrow: inferior wall, white dotted arrow: lateral wall). Cardiac short-axis (A), vertical long-axis (B), hor izontal long-
axis (C) was represented. The polar map (D) an image showing quantified values of perfusion of each cardiac region as a map.
Fig. 3. These images represent the cardiac wall motion reconstructed as 3 dimensional image. The cardiac wall motion images showe d
a visualization of the radioactivity of 
99mTc-tetrofosmin in the heart and cardiac perfusion volume. A: end-diastole volume B: end-
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case, an EF of 79% was calculated from the ventricular
volume of the ES image (10 ml) on the left subtracted from
that of the ED volume (49 ml) on the right. The ES images
below show excellent myocardial thickening compared with
the ED images shown in Fig. 4A. As shown in Table 2, the
mild to moderate defect was observed in Pig 3, but a
perfusion defect (especially, apex, lateral wall) is unlikely
because of the presence of a preserved wall motion in a
segment with a defect [2].
Discussion
99mTc-tetrofosmin is a lipophilic, cationic diphosphine,
and the more recent of the technetium-labeled perfusion
tracers for a diagnosis and risk stratification of coronary
artery disease (CAD). It enters myocardial cells through
passive transport driven by the negative membrane potential
of the intact cell. Once within the myocardium it is localized
mainly within the cytosol and only a fraction passes into the
mitochondria [1,11,18]. The biological half-life for the
normal myocardium is approximately 5 h. The blood clearance
of tetrofosmin is quite rapid; <5% of the residual activity is
present after 10 min. Although the diagnostic sensitivity in
mild to moderate CAD appears to be similar, tetrofosmin
does not undergo significant redistribution from its initial
pattern of uptake. Therefore, imaging can be performed for
up to 4 h after the injection. There are only two important
differences between sestamibi and tetrofosmin. The first is
that the preparation of tetrofosmin does not require a boiling
step. Second, perhaps more importantly, the hepatic clearance
of tetrofosmin is more rapid [4,10].
Myocardial SPECT (M- SPECT) is a well-established and
important technique for the diagnosis and risk stratification
of patients with CAD [6-9,12,16]. Millions of studies are
performed each year, highlighting the significant clinical
need addressed by this methodology. For patients with
radionuclide evidence of ischemia, the positive
 predictive
value of such testing is uniformly low, in the range
 of 4% to
20%. However, the negative predictive value of a normal
scan is very high (96% to 100%). The positive predictive
value
 of perfusion imaging can be improved when testing is
applied
 selectively to patients with a higher pretest likelihood
of
 CAD and when the results are integrated into a clinical
risk
 assessment [8]. M-SPECT adds incremental prognostic
information when used
 in patients who have not undergone
prior catheterization
 or revascularization and have not had
any previous myocardial infarctions
 and are at overall low to
intermediate risk (1.8% hard event
 rate, 1.2% per year of
follow-up). Furthermore, veterinarians refer
  patients to
catheterization and revascularization according to the extent
and severity of their scan results, and hence,
 to their risk of
cardiac events. Therefore, the effect
 of testing on patient
management appears to be both powerful
 and appropriate
[5].
Myocardial perfusion imaging showed a higher sensitivity
for detecting disease (92%), as well as a higher specificity
for ruling out the presence of disease (80%) [15]. Gated
SPECT imaging has significantly improved the practice of
nuclear cardiology with respect to assessing the cardiac
function and artifact determination. The counts detected
during other periods of the cardiac cycle, as determined by
ECG timing, will be applied to the corresponding image
showing a particular moment in the cardiac cycle. These
static images represent the degree of ventricular thickening
during a single cardiac cycle. The degree of ventricular
thickening and EF can be calculated if these images are run
in a continuous loop. The proper identification of artifacts is
a major advantage of gated SPECT imaging. DePuey et al.
[2] suggested that the presence of a preserved wall motion in
a segment with a fixed defect is indicative of an artifact
rather than an infarct. They reported that this type of
Fig. 4. Images representing the quantitative wall motion and thickening that provides evidence of the ventricular function. A: thicken ing
(above: end-diastolic image, below: end-systolic image), B: thickening map.
Table 2. The defect severity evaluated using a semiquantitative
five-point scoring system
Apect Anterior Lateral Inferior Septum
P i g  1 00000
P i g  2 00100
P i g  3 1 - 201 - 20 0Assessment of cardiac function in micropig 227
analysis could reduce the false-positive rate significantly. In
conclusion, quantitative cardiac scintigraphy using 
99mTc-
tetrofosmin is a good technique for estimating the heart
functions of healthy micropigs.
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